Literature DB >> 20667822

The crystal structure of human transketolase and new insights into its mode of action.

Lars Mitschke1, Christoph Parthier, Kathrin Schröder-Tittmann, Johannes Coy, Stefan Lüdtke, Kai Tittmann.   

Abstract

The crystal structure of human transketolase (TKT), a thiamine diphosphate (ThDP) and Ca(2+)-dependent enzyme that catalyzes the interketol transfer between ketoses and aldoses as part of the pentose phosphate pathway, has been determined to 1.75 Å resolution. The recombinantly produced protein crystallized in space group C2 containing one monomer in the asymmetric unit. Two monomers form the homodimeric biological assembly with two identical active sites at the dimer interface. Although the protomer exhibits the typical three (α/β)-domain structure and topology reported for TKTs from other species, structural differences are observed for several loop regions and the linker that connects the PP and Pyr domain. The cofactor and substrate binding sites of human TKT bear high resemblance to those of other TKTs but also feature unique properties, including two lysines and a serine that interact with the β-phosphate of ThDP. Furthermore, Gln(189) spans over the thiazolium moiety of ThDP and replaces an isoleucine found in most non-mammalian TKTs. The side chain of Gln(428) forms a hydrogen bond with the 4'-amino group of ThDP and replaces a histidine that is invariant in all non-mammalian TKTs. All other amino acids involved in substrate binding and catalysis are strictly conserved. Besides a steady-state kinetic analysis, microscopic equilibria of the donor half-reaction were characterized by an NMR-based intermediate analysis. These studies reveal that formation of the central 1,2-dihydroxyethyl-ThDP carbanion-enamine intermediate is thermodynamically favored with increasing carbon chain length of the donor ketose substrate. Based on the structure of human transketolase and sequence alignments, putative functional properties of the related transketolase-like proteins TKTL1 and -2 are discussed in light of recent findings suggesting that TKTL1 plays a role in cancerogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667822      PMCID: PMC2951230          DOI: 10.1074/jbc.M110.149955

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Refined structure of transketolase from Saccharomyces cerevisiae at 2.0 A resolution.

Authors:  M Nikkola; Y Lindqvist; G Schneider
Journal:  J Mol Biol       Date:  1994-05-06       Impact factor: 5.469

2.  Snapshot of a key intermediate in enzymatic thiamin catalysis: crystal structure of the alpha-carbanion of (alpha,beta-dihydroxyethyl)-thiamin diphosphate in the active site of transketolase from Saccharomyces cerevisiae.

Authors:  Erik Fiedler; Stina Thorell; Tatyana Sandalova; Ralph Golbik; Stephan König; Gunter Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

3.  Molecular evolutionary analysis of the thiamine-diphosphate-dependent enzyme, transketolase.

Authors:  G Schenk; R Layfield; J M Candy; R G Duggleby; P F Nixon
Journal:  J Mol Evol       Date:  1997-05       Impact factor: 2.395

4.  Transketolase haploinsufficiency reduces adipose tissue and female fertility in mice.

Authors:  Zheng-Ping Xu; Eric F Wawrousek; Joram Piatigorsky
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

5.  An erythrocyte transketolase isoenzyme pattern associated with the Wernicke-Korsakoff syndrome.

Authors:  P F Nixon; M J Kaczmarek; J Tate; R A Kerr; J Price
Journal:  Eur J Clin Invest       Date:  1984-08       Impact factor: 4.686

6.  Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes.

Authors:  J F Coy; S Dübel; P Kioschis; K Thomas; G Micklem; H Delius; A Poustka
Journal:  Genomics       Date:  1996-03-15       Impact factor: 5.736

7.  Heterologous expression of human transketolase.

Authors:  G Schenk; R G Duggleby; P F Nixon
Journal:  Int J Biochem Cell Biol       Date:  1998-03       Impact factor: 5.085

8.  Strain and near attack conformers in enzymic thiamin catalysis: X-ray crystallographic snapshots of bacterial transketolase in covalent complex with donor ketoses xylulose 5-phosphate and fructose 6-phosphate, and in noncovalent complex with acceptor aldose ribose 5-phosphate.

Authors:  Peter Asztalos; Christoph Parthier; Ralph Golbik; Martin Kleinschmidt; Gerhard Hübner; Manfred S Weiss; Rudolf Friedemann; Georg Wille; Kai Tittmann
Journal:  Biochemistry       Date:  2007-10-03       Impact factor: 3.162

9.  TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization.

Authors:  Wenyue Sun; Yan Liu; Chad A Glazer; Chunbo Shao; Sheetal Bhan; Semra Demokan; Ming Zhao; Michelle A Rudek; Patrick K Ha; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

10.  A common structural motif in thiamin pyrophosphate-binding enzymes.

Authors:  C F Hawkins; A Borges; R N Perham
Journal:  FEBS Lett       Date:  1989-09-11       Impact factor: 4.124

View more
  28 in total

1.  Sub-ångström-resolution crystallography reveals physical distortions that enhance reactivity of a covalent enzymatic intermediate.

Authors:  Stefan Lüdtke; Piotr Neumann; Karl M Erixon; Finian Leeper; Ronald Kluger; Ralf Ficner; Kai Tittmann
Journal:  Nat Chem       Date:  2013-08-18       Impact factor: 24.427

Review 2.  Mechanistic aspects of carotenoid biosynthesis.

Authors:  Alexander R Moise; Salim Al-Babili; Eleanore T Wurtzel
Journal:  Chem Rev       Date:  2013-10-31       Impact factor: 60.622

3.  Twisted Schiff base intermediates and substrate locale revise transaldolase mechanism.

Authors:  Anja Lehwess-Litzmann; Piotr Neumann; Christoph Parthier; Stefan Lüdtke; Ralph Golbik; Ralf Ficner; Kai Tittmann
Journal:  Nat Chem Biol       Date:  2011-08-21       Impact factor: 15.040

4.  A preliminary X-ray study of transketolase from Burkholderia pseudomallei.

Authors:  Mi Sun Kim; Areum Lim; Seung Won Yang; Daeun Lee; Jimin Park; Dong Hae Shin
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-11-28

5.  Akt phosphorylation and regulation of transketolase is a nodal point for amino acid control of purine synthesis.

Authors:  Arindam Saha; Stephen Connelly; Jingjing Jiang; Shunhui Zhuang; Deron T Amador; Tony Phan; Renate B Pilz; Gerry R Boss
Journal:  Mol Cell       Date:  2014-06-26       Impact factor: 17.970

6.  Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.

Authors:  Carmela Ricciardelli; Noor A Lokman; Sowmya Cheruvu; Izza A Tan; Miranda P Ween; Carmen E Pyragius; Andrew Ruszkiewicz; Peter Hoffmann; Martin K Oehler
Journal:  Clin Exp Metastasis       Date:  2015-04-21       Impact factor: 5.150

7.  Thiamin Diphosphate Activation in 1-Deoxy-d-xylulose 5-Phosphate Synthase: Insights into the Mechanism and Underlying Intermolecular Interactions.

Authors:  Justin K White; Sumit Handa; Sai Lakshmana Vankayala; David J Merkler; H Lee Woodcock
Journal:  J Phys Chem B       Date:  2016-09-12       Impact factor: 2.991

8.  DXP synthase-catalyzed C-N bond formation: nitroso substrate specificity studies guide selective inhibitor design.

Authors:  Francine Morris; Ryan Vierling; Lauren Boucher; Jürgen Bosch; Caren L Freel Meyers
Journal:  Chembiochem       Date:  2013-07-03       Impact factor: 3.164

9.  Diphenyl urea derivatives as inhibitors of transketolase: a structure-based virtual screening.

Authors:  Cristian Obiol-Pardo; Gema Alcarraz-Vizán; Marta Cascante; Jaime Rubio-Martinez
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

10.  A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.

Authors:  Stefan Schneider; Stefan Lüdtke; Kathrin Schröder-Tittmann; Cindy Wechsler; Danilo Meyer; Kai Tittmann
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.